RxDoctor Payments Data

Charles Benner, MD

Internal Medicine · Solomons, MDNPI 1902872435

Payments from drug & device makers

$1,246in general payments, 2019–2025

Across 68 payments — averaging $18.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$185
  • Novo Nordisk$173
  • Lilly USA, LLC$149
  • Boehringer Ingelheim$109
  • Astellas Pharma US Inc$97
  • Merck$91
  • plus $443 from 11 others

What the payments were for

  • Food & beverage$1,246100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,246 in reported general payments places this provider in the 75th percentile of 2,979 internal medicine providers in Maryland.

See all internal medicine providers in Maryland

Medicare billing

Part B allowed, 2024
$113,419
Medicare patients
415
Services billed
1,144

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban146$86,945
OzempicSemaglutide42$61,822
JanuviaSitagliptin Phosphate21$22,274
JardianceEmpagliflozin25$17,770
MyrbetriqMirabegron22$14,970
XareltoRivaroxaban12$14,793
TrulicityDulaglutide14$13,401
CreonLipase/Protease/Amylase22$12,251
Atorvastatin Calcium327$4,637
Novolog FlexpenInsulin Aspart12$4,266
ProzacFluoxetine Hcl11$4,012
Tresiba Flextouch U-100Insulin Degludec22$3,395
Esomeprazole Magnesium33$2,853
Lidocaine16$2,657
Duloxetine Hcl67$2,563

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$65$86,945146 claims
Novo NordiskOzempic$173$61,82242 claims
MerckJanuvia$91$22,27421 claims
Boehringer IngelheimJardiance$109$17,77025 claims
Astellas Pharma US IncMyrbetriq$97$14,97022 claims
Lilly USA, LLCTrulicity$149$13,40114 claims
AbbVieCreon, Synthroid$185$13,17540 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,979 internal medicine providers in Maryland.

Other internal medicine in Solomons

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →